HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xing Tang Selected Research

Disulfiram (Antabuse)

6/2022Sphingomyelin-based PEGylation Cu (DDC)2 liposomes prepared via the dual function of Cu2+ for cancer therapy: Facilitating DDC loading and exerting synergistic antitumor effects.
6/2018Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
5/2018Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.
1/2018mPEG5k- b-PLGA2k/PCL3.4k/MCT Mixed Micelles as Carriers of Disulfiram for Improving Plasma Stability and Antitumor Effect in Vivo.
1/2018Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors.
2/2016Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
11/2015A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
9/2014Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo.
10/2013A novel UPLC-ESI-MS/MS method for the quantitation of disulfiram, its role in stabilized plasma and its application.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xing Tang Research Topics

Disease

65Neoplasms (Cancer)
06/2022 - 04/2008
7Lung Neoplasms (Lung Cancer)
01/2022 - 07/2013
7Hemolysis
10/2018 - 01/2010
6Inflammation (Inflammations)
06/2022 - 01/2012
6Breast Neoplasms (Breast Cancer)
12/2020 - 01/2012
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2018
4Pain (Aches)
01/2021 - 10/2006
4Anaphylaxis (Anaphylactic Shock)
10/2018 - 01/2010
3Neoplasm Metastasis (Metastasis)
01/2022 - 07/2015
3Hepatocellular Carcinoma (Hepatoma)
01/2021 - 02/2020
3Carcinoma (Carcinomatosis)
01/2021 - 06/2010
3Infections
01/2021 - 09/2003
3Dehydration (Water Stress)
02/2020 - 11/2013
3Body Weight (Weight, Body)
08/2017 - 11/2016
2Prostatic Neoplasms (Prostate Cancer)
10/2021 - 01/2014
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2011
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 05/2019
2Rheumatoid Arthritis
04/2020 - 01/2020
2Macular Degeneration (Age-Related Maculopathy)
01/2020 - 01/2020
2Glioma (Gliomas)
01/2020 - 09/2014
2Eye Diseases (Eye Disease)
01/2020 - 07/2009
2Alzheimer Disease (Alzheimer's Disease)
01/2019 - 09/2018
2Adenocarcinoma
01/2014 - 07/2013
2Myocardial Ischemia (Ischemic Heart Diseases)
08/2012 - 05/2008
1Acute Kidney Injury (Acute Renal Failure)
06/2022
1Phlebitis
06/2022
1Granuloma
01/2022
1Cardiotoxicity
01/2022
1Pancreatitis
11/2021
1Myopia
11/2021

Drug/Important Bio-Agent (IBA)

31Pharmaceutical PreparationsIBA
06/2022 - 01/2010
10MicellesIBA
02/2022 - 01/2012
9Therapeutic UsesIBA
06/2022 - 07/2015
9Disulfiram (Antabuse)FDA Link
06/2022 - 10/2013
9SolutionsIBA
06/2021 - 10/2006
7LipidsIBA
01/2022 - 07/2012
6Liposomes (Liposome)IBA
06/2022 - 02/2013
5CopperIBA
06/2022 - 11/2015
5Cisplatin (Platino)FDA LinkGeneric
02/2022 - 01/2019
5PolymersIBA
01/2022 - 12/2008
5Biological ProductsIBA
01/2022 - 03/2010
5EmulsionsIBA
11/2013 - 10/2006
4Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2012
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 03/2010
4Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 01/2018
4GelsIBA
01/2020 - 09/2014
3Vinorelbine (Navelbine)FDA LinkGeneric
06/2022 - 01/2018
3Polymethyl Methacrylate (Sol)IBA
01/2022 - 01/2018
3LigandsIBA
10/2021 - 01/2014
3PlatinumIBA
05/2021 - 01/2019
3ProdrugsIBA
05/2021 - 07/2015
3monomethoxypolyethylene glycol (MPEG)IBA
01/2021 - 06/2018
3CurcuminIBA
12/2020 - 01/2018
3Antineoplastic Agents (Antineoplastics)IBA
10/2020 - 09/2014
3HydrogelsIBA
04/2020 - 08/2017
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 - 09/2014
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020 - 03/2010
3Peptides (Polypeptides)IBA
05/2018 - 11/2015
3Clarithromycin (Biaxin)FDA LinkGeneric
02/2013 - 10/2006
2N-Acetylneuraminic Acid (Sialic Acid)IBA
06/2022 - 07/2020
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 09/2003
2Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
06/2022 - 02/2020
2AcidsIBA
06/2022 - 05/2008
2norcantharidinIBA
01/2022 - 10/2020
2GemcitabineFDA Link
06/2021 - 10/2018
2Small Interfering RNA (siRNA)IBA
05/2021 - 04/2020
2Glutamic Acid (Glutamate)FDA Link
01/2021 - 01/2018
2SuspensionsIBA
10/2020 - 01/2019
22- tetradecylhexahydro- 1H- 4,7- epoxyisoindole- 1,3(2H)- dioneIBA
10/2020 - 03/2017
2Matrix Metalloproteinases (MMPs)IBA
04/2020 - 10/2017
2Methotrexate (Mexate)FDA LinkGeneric
04/2020 - 01/2020
2Indomethacin (Indometacin)FDA LinkGeneric
04/2020 - 01/2020
2Triglycerides (Triacylglycerol)IBA
01/2020 - 03/2010
2NanocapsulesIBA
01/2020 - 11/2015
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2019 - 10/2017
2Azithromycin (Zithromax)FDA LinkGeneric
11/2018 - 07/2009
2GinsenosidesIBA
09/2018 - 08/2012
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 06/2010
2monomethoxy(polyethylene glycol)-b-poly(lactic-co-glycolic acid)-b-poly(glutamic acid)IBA
01/2018 - 04/2015
2Docetaxel (Taxotere)FDA Link
09/2017 - 01/2012
2Blood Glucose (Blood Sugar)IBA
08/2017 - 11/2016
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2017 - 02/2014
1GlucocorticoidsIBA
06/2022
1SphingomyelinsIBA
06/2022
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
06/2022
1OX40 LigandIBA
06/2022
1homocamptothecinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1nintedanibIBA
01/2022
1Long Noncoding RNAIBA
11/2021
1Emodin (Archin)IBA
11/2021
1AtropineFDA LinkGeneric
11/2021

Therapy/Procedure

17Therapeutics
06/2022 - 04/2008
13Drug Therapy (Chemotherapy)
06/2022 - 07/2012
3Intravenous Administration
06/2022 - 05/2013
2Contact Lenses
10/2019 - 10/2018
2Lasers (Laser)
01/2019 - 03/2010
2Microspheres (Microsphere)
01/2019 - 05/2013
2Intravenous Injections
06/2010 - 01/2010
1Oral Administration
06/2022